Our European relations and Grant officer (Katja) gave a talk at the University of Cambridge in November 2018. The presentation was part of the "Open Access to Drug Discovery"-Day organised by Dr Cathy Boucher - Senior Research Facilitator Cambridge Academy of Therapeutic Sciences.
EU-OPENSCREEN is a European Research Infrastructure Consortium (ERIC) founded in 2018 by seven European Countries. It integrates high capacity screening platforms throughout Europe, which jointly use a rationally selected compound collection, comprising of 140,000 commercial and proprietary compounds collected from European chemists. The EU-OPENSCREEN central office in Berlin, is in the process of being established, and they are anticipating that the first screens using the EU-OPENSCREEN compound collection will take place in Autumn 2019.
Although services and compounds are openly available, funding is required to meet compound, reagent and staff costs. EU-OPENSCREEN is happy to help with writing grants for appropriate funding. In addition, they have been awarded funding by the EU to support approximately 12 research projects. University of Cambridge researchers are able to access services from EU-OPENSCREEN although the UK is not a member state of EU-OPENSCREEN.